TASIMELTEON, HETLIOZ 20 mg hard capsules
VP-VEC-162-3202
Phase 3 small_molecule active
Quick answer
TASIMELTEON, HETLIOZ 20 mg hard capsules for Non-24 Hour Sleep-Wake Disorder is a Phase 3 program (small_molecule) at Pharma Mar S.A. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pharma Mar S.A.
- Indication
- Non-24 Hour Sleep-Wake Disorder
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active